An in vitro study on the compatibility and concentrations of combinations of vancomycin, amikacin, and dexamethasone in human vitreous

Eye

Volumn 21, Issue 5, 2007, Pages 643-648

  Hui, M ^a   Kwok, A K H ^b   Pang, C P ^b   Cheung, S W ^a   Lam, D S C ^b   Chan, R C Y ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BALANCED SALT SOLUTION; DEXAMETHASONE SODIUM PHOSPHATE; SODIUM CHLORIDE; VANCOMYCIN;

ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; ENDOPHTHALMITIS; EQUILIBRIUM DIALYSIS; FLUORESCENCE POLARIZATION IMMUNOASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INCUBATION TIME; PRECIPITATION; STATISTICAL SIGNIFICANCE; VITREOUS BODY;

EID: 34248332575     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702321     Document Type: Article

References (23)

1. Shrader SK, Band JD, Lauter CB, Murphy P. The clinical spectrum of endophthalmitis: Incidence, predisposing factors, and features influencing outcome. J Infect Dis 1990; 162: 115-120.
2. Kunimoto DY, Das T, Sharma S, Jalali S, Majji AB, Gopinathan U et al. Microbiologic spectrum and susceptibility of isolates: Part I. Postoperative endophthalmitis. Endophthalmitis Research Group. Am J Ophthalmol 1999; 128: 240-242.
3. Kunimoto DY, Das T, Sharma S, Jalali S, Majji AB, Gopinathan U et al. Microbiologic spectrum and susceptibility of isolates: Part II. Posttraumatic endophthalmitis. Endophthalmitis Research Group. Am J Ophthalmol 1999; 128: 242-244.
4. Benz MS, Scott IU, Flynn Jr HW, Unonius N, Miller D. Endophthalmitis isolates and antibiotic sensitivities: A 6-year review of culture-proven cases. Am J Ophthalmol 2004; 137: 38-42.
5. Yam JC, Kwok AK. Update of the management of postoperative endophthalmitis. Hong Kong Med J 2004; 10: 337-343.
6. Park SS, Samiy N, Ruoff K, D'Amico DJ, Baker AS. Effect of intravitreal dexamethasone in treatment of pneumococcal endophthalmitis in rabbits. Arch Ophthalmol 1995; 113: 1324-1329.
7. Das T, Jalali S, Gothwal VK, Sharma S, Naduvilath TJ. Intravitreal dexamethasone in exogenous bacterial endophthalmitis: Results of a prospective randomised study. Br J Ophthalmol 1999; 83: 1050-1055.
8. Yoshizumi MO, Bhavsar AR, Dessouki A, Kashani A. Safety of repeated intravitreous injections of antibiotics and dexamethasone. Retina 1999; 19: 437-441.
9. Fiscella RG. Physical incompatibility of vancomycin and ceftazidime for intravitreal injection. Arch Ophthalmol 1993; 111: 730.
10. Kwok AK, Hui M, Pang CP, Chan RC, Cheung SW, Yip CM et al. An in vitro study of ceftazidime and vancomycin concentrations in various fluid media: Implications for use in treating endophthalmitis. Invest Ophthalmol Vis Sci 2002; 43: 1182-1188.
11. Hui M, Kwok AK, Pang CP, Cheung SW, Chan RC, Lam DS et al. An in vitro study on the compatibility and precipitation of a combination of ciprofloxacin and vancomycin in human vitreous. Br J Ophthalmol 2004; 88: 218-222.
12. Kwak HW, D'Amico DJ. Determination of dexamethasone sodium phosphate in the vitreous by high performance liquid chromatography. Korean J Ophthalmol 1995; 9: 79-83.
13. Eliopoulos GM, Moellering RC. Antimicrobial combinations. In: Lorian V (ed). Antibiotics in Laboratory Medicine. Williams & Wilkins: Baltimore, 1996, pp 333.
14. Barre J, Chamouard JM, Houlin G. Tillement JP. Equilibrium dialysis, ultrafiltration, and ultracentrifugation compared for determining the plasma-protein-binding characteristics of valproic acid. Clin Chem 1985; 31: 60-64.
15. Lifshitz T, Lapid-Gortzak R. Finkelman Y. Klemperer I. Vancomycin and ceftazidime incompatibility upon intravitreal injection. Br J Ophthalmol 2000; 84: 117-118.
16. Pfaller MA, Krogstad DJ, Granich GG, Murray PR. Laboratory evaluation of five assay methods for vancomycin: Bioassay, high-pressure liquid chromatography, fluorescence polarization immunoassay, radioimmunoassay, and fluorescence immunoassay. J Clin Microbiol 1984; 20: 311-316.
17. Ngui-yen JH, Doyle PW, Smith JA. Comparative analysis of two rapid, automated methods for determining aminoglycosides levels. J Clin Microbiol 1984; 20: 962-965.
18. Alster Y, Herlin L, Lazar M, Loewenstein A. Intraocular penetration of vancomycin eye drops after application to the medial canthus with closed lids. Br J Ophthalmol 2000; 84: 300-302.
19. Smith MA, Sorenson JA, Smith C, Miller M, Borenstein M. Effects of intravitreal dexamethasone on concentration of intravitreal vancomycin in experimental methicillin-resistant Staphylococcus epidermidis endophthalmitis. Antimicrob Agents Chemother 1991; 35: 1298-1302.
20. Park SS, Vallar RV, Hong CH, von Gunten S, Ruoff K, D'Amico DJ. Intravitreal dexamethasone effect on intravitreal vancomycin elimination in endophthalmitis. Arch Ophthalmol 1999; 117: 1058-1062.
21. Blumenkranz MS, Claflin A, Hajek AS. Selection of therapeutic agents for intraocular proliferative disease. Cell culture evaluation. Arch Ophthalmol 1984; 102: 598-604.
22. Campochiaro PA, Lim JI. Aminoglycoside toxicity in the treatment of endophthalmitis. The Aminoglycoside Toxicity Study Group. Arch Ophthalmol 1994; 112: 48-53.
23. Donahue SP, Kowalski RP, Eller AW, DeVaro JM, Jewart BH. Empiric treatment of endophthalmitis. Are aminoglycosides necessary? Arch Ophthalmol 1994; 112: 45-47.